You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Articles Characteristics of the Sentinel Lymph Node in Breast Cancer Predict Further Involvement of Higher-Echelon Nodes in the Axilla: A Study to Evaluate the Need for Complete Axillary Lymph Node Dissection
Vidyulata J. Kamath; Rosemary Giuliano; Emilia L. Dauway; Alan Cantor; Claudia Berman; Ni Ni Ku; Charles E. Cox; Douglas S. Reintgen
Arch Surg 2001; 136: 688-692.
[Abstract][Full text][PDF]
Invited Critique Characteristics of the Sentinel Lymph Node in Breast Cancer Predict Further Involvement of Higher-Echelon Nodes in the AxillaInvited Critique
Papers Underlying Liver Disease, Not Tumor Factors, Predicts Long-term Survival After Resection of Hepatocellular Carcinoma
Malcolm M. Bilimoria; Gregory Y. Lauwers; Dorota A. Doherty; David M. Nagorney; Jacques Belghiti; Kim-Anh Do; Jean-Marc Regimbeau; Lee M. Ellis; Steven A. Curley; Iwao Ikai; Yoshio Yamaoka; Jean-Nicolas Vauthey
Arch Surg 2001; 136: 528-535.
[Abstract][Full text][PDF]
Papers Adrenocortical Carcinoma: Surgical Progress or Status Quo?
Michael L. Kendrick; Ricardo Lloyd; Lori Erickson; David R. Farley; Clive S. Grant; Geoffrey B. Thompson; Charles Rowland; William F. Young Jr; Jon A. van Heerden
Arch Surg 2001; 136: 543-549.
[Abstract][Full text][PDF]
Original Articles DNA Flow Cytometry Does Not Predict 5- or 10-Year Recurrence Rates for T1-2 Node-Negative Breast Cancer
Donald N. Reed Jr; Jon Johnson; Philip Richard; Stanley McCormick; Nancy Shannon; Raouf A. Mikhail; Janet Osuch; Patricia B. Cerrito; Kelly M. McMasters
Arch Surg 2000; 135: 1422-1426.
[Abstract][Full text][PDF]
Original Articles The Association of HER-2/neu Amplification With Breast Cancer Recurrence
John Alfred Carr; Suzanne Havstad; Richard J. Zarbo; George Divine; Pat Mackowiak; Vic Velanovich
Arch Surg 2000; 135: 1469-1474.
[Abstract][Full text][PDF]
Original Articles Echogenicity of Liver Metastases Is an Independent Prognostic Factor After Potentially Curative Treatment
Thomas Gruenberger; Jean-Luc Jourdan; Jing Zhao; Julie King; David Lawson Morris
Arch Surg 2000; 135: 1285-1290.
[Abstract][Full text][PDF]
Original Articles Intra-arterial Iodine 131Labeled Lipiodol as Adjuvant Therapy After Curative Liver Resection for Hepatocellular Carcinoma: A Phase 2 Clinical Study
Christian Partensky; Genevieve Sassolas; Luc Henry; Pierre Paliard; Guy J. Maddern
Arch Surg 2000; 135: 1298-1300.
[Abstract][Full text][PDF]
Original Articles Is the p53 Gene Mutation of Prognostic Value in Hepatocellular Carcinoma After Resection?